PCM
SRRA

Prelude Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Prelude Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-47,885
Closed -$2.63M – 2025
2022
Q2 		$2.63M Buy
+47,885
New +$2.63M 0.07% 167